ASHLEY RUFFING: Open Payments
NPI 1730629718 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,150 in 57 payments from 15 companies in 2025. Trend: 2023 $741 · 2024 $998 · 2025 $1,150
Food & beverage: $1,150
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 25 | $422 |
| AstraZeneca Pharmaceuticals LP | 16 | $357 |
| Insmed, Inc. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| GENZYME CORPORATION | 1 | $34 |
| Philips North America LLC | 1 | $33 |
| United Therapeutics Corporation | 1 | $31 |
| Grifols USA, LLC | 1 | $27 |
| HARMONY BIOSCIENCES LLC | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
Products named: NUCALA, TRELEGY ELLIPTA, TEZSPIRE, AIRSUPRA, DUPIXENT, BREZTRI, Arikayce, Vest Therapy Und.
Industry payments across FL — which companies pay providers there.
